A Dr. Agarwal'sEye Hospital Ltd.

For eyes like new

May 28, 2018

Dept. of Corporate Services

Corporate Relationship DepartmentBSE Ltd

PhirozeJeejeebhai Towers,

Dalal Street,

Mumbai ~400001

Dear Sirs,

Sub: Outcome of the Board Meeting held on 28‘“ May 2018

Ref: 1) Regulation 33 of SEBI (LODR) Regulations 2015

2) Scrip Code: 526783

The Board of directors of the company at its meeting held today:

1. Approved and have taken on record the Audited Financial Results for the quarter and

financial year ended 31St March 2018. In this regard, please find enclosed copies of the

following:

i. Statement showing the Audited Financial Results for the quarter and

financial year ended 31St March 2018.

ii. Auditors’ Report on the said Financial Results.

iii. Declaration in respect of the Auditors‘ Report with Unmodified Opinion

2. The Board of Directors have recommended a dividend of 12% on the paid up equity share

Capital subject to approval of the shareholders at the ensuing Annual General Meeting.

3. The Company has also made arrangements for release of the Audited Results in the

newspapers as per the requirement ofthe SEBI (LODR) regulations 2015.

4. Approved and took on record the resignation of Mr.R. Sabesan, Chief Financial Officer of

the Company with effect from 315‘ March 2018.

Kindly take the above information on record.

Thanking you,

Yours sincerely,

Wu“ ,

R. AMAR AGARWAL

AIRMAN AND MANAGING DIRECTOR

Registered Office

3'“ Floor, Buhari Towers. No.4, Moores Road, Ofi Greams Road, Near Asan Memorial School, Chennai - 600 006.

Tel: 91-44-3991 6600 Fax: 91-44-3991 6645‘

Corporate ID Number: L85110TN1994PL0027366 GST No. 33AAACD2373G122

Email: dragarwal@vsnl.com | Website: wwwdragarwai.oom

'0

Dr.

Agarwal'sEyeHospitalLimlled

CIN:

L85110TN1994PLCL‘27355

R5941Office:3rd

Floor,Eunal‘lTowers,No.4

Moore:Road,0"61531115Road,Chennal

-

600DDS

PhoneNo.

514449916559Wehsixe

:www.dragarwal.comE-ma

:

lnvestar@dmgar11val.com

(AmountIn

R51

Lakhs)

Slammentof

AudlkedFlnancialResultsfortheVearEnded31

March2018

S.Nn.

Pamnulars

nuanerEnded

YearEnded

21

.Mar.15

(mmMax.3)

31-Dec-17

31<Mar~17

Unaudimi

(Rev-rNum3)

CILMar-Ia

Audilzd

31-Mar-17 Audited

Incvma (a)

RevenuefromOperalinns

(b)

otherIncama

Tomlncom:

Expansss (a)

PurchaseolSIOCk—in-Trada

(5)

ChangesIn

Invenioriasoi

Slackalna'l'rzda.

(Increase)(05015555

(1:)

Consumihlas(a)

Consullincycharges

(a)

EmplnyeaBenafiIExpansas

(1)

Financesass

(g)

DanmciaflnnandAmonisamonExpansa

(n)

Rent(0

omarExpenses

TulalExnansos

Profit](Loss)halal:ExcanlinnzlnunsandTax(1-2)

ExcaplionalReins

PramI

(Loss)MoreTax13-4)

TaxExpense .

CurrantTax(lnclud

g

pflnryaars)

.

0515mmTax

Natpmm7(Loss)mar1ax1onnaperiud(55)

OmarComprehensiveIncarn-

(a)

Iiamsmam

nothe

radasslfiedIn

ma

Statementanmmand

Loss

aAmuarlal(loss)(gainan

dafinndnanamahmaflnn

-

DamnedTaxon

Mjus1mams

(b)

11517151112114"be

Vaclassifiedla

Illa

Slalamanlof

Fmfiland

LESS

151:1011mCamprehen

a

IncnmeI

(Loss)(n51o1m)

TomcomprehensiveIncnmn/(Lass)(155)

F

up

aqunysham

1:5

Rasamas(OmarEquity)

EarningsPer

EquilyShara(EPs)(FaceValuenfRs1fl/—aacn)

(a)

5:55(In)

Ddulad

I

(FacevaIua115.10

CBC?!)

3757.55 65.45

3,450.75

3.51025

35.35

15

39

15332.13 230.00

14.55415

155.35

3

524.41

3

555.14

3

555.57

15

552.13

15013.54

523.43 (19

54)

397.54 512.13 741.25 55.50 235.23 443.03 715.25

315.51

253.55

95.91

(1063)

392.51

314.31

515.05

510.57

55522

722.57

57.55

75

53

25354

272.45

43753

42445

750.55

515,75

1

595.47 (51

52)

1.541.74

2.00275 3,155.03 259.54 375.151

717.55 2.71357

1,751.75 72.52 1,553.14 1

535.34 3,243.33 333.30 574.15 1,544.09 2.37541

3550.54

3

7511.43

3

174131

14

225.04

13

522.05

1

73.57 113.57 146.55 11541

(204.23)

51I

.35

(254.20)

51

1.35

(2550)

20545

(44.35)

(40.35)

1.335.113 1,335.09 544.35 14.22

1.33115 1,057.45 455.00 (95.35)

(53.35)

(132.51)

343.25

577.52

733.53

(13.32) 2.51

(5.26)

(40.57)

2.55

14.14

(35.19) 11

12

(40.75) 14.10

(10.51)

(540)

[25.73)

(27.57)

(25.55)

(34.20) 470.00 (1

.77)(1

.77)

(runAnnualisad)

(135.21)

315.55

470.110

47000

(2

53)

7.50

(2.53)

7.30

(7101AnnuaIisea)

(noiAnnuasad)

550.45 470.00 31135.31 14.42 14.42

(Annna

an

707.15

470.00 2470.31 1551 15.51

(Annuallsad)

6

Dr.

Agarwal'sEye

Hospital

mited

CIN

.

L85110TN1994PLC027366

RegdOffice:3rd

Floor,BuhariTowers,No.4,MooresRoad,OffGreamsRnad,Chenna

-

600

006

PhoneNo.

9144-39916669Website:

www.dragarwal.comE-mail:

investoerragarwal.com

(Amountin

Rs.

Lakhs)

BALANCESHEET

Asat

Paniculars

31-Mar-15

31-Mar~17

a1~Apr~15

Au

:1

Audited

Au

:1

A

ASSETS1

Non-currentassets

(6)

Pmpeny,plantandequlpmenl

3,21566

5,25207

5,59062

(b)

Caplla]work

n-pmgress

34276

121

53

76

20

(e)

Olnarlntangito

assets

:4552

55

57

12

55

(a)

Ftnzncialassets

—

Loans

1.01514

03301

75546

(e)

Non-currenltax

assets(net)

165.53

29327

454

03

(I)

naIei-rao(ax

assets(net)

65697

650.07

545.62

(9)0012!nun

currentassets

54.56

9.64

40

43

TotalNan

.

CurrentAssets

5,197.44

5,255.66

5,243.59

2

Currentasse1s

(a)

lnventones

755.55

512.54

965.60

(b)

Flnal’lclalassets

(i)

Tradereceivables

707.10

662.80

750.65

(ii)

Cashand

cashequivalents

182

65

228

56

185

5:

i)

Bankbalancesotherthan

I

above

55,865

56.51

55.90

(iv)

Lnans

.

5,74

5550

(v)

omerFlnancllAssets

205

07

100

55

97

69

(c)

Othercurrenlassets

41562

527.62

554

06

You]CurrentAssets

2,500.05

1,594.94

2.494.95

TotalAssets(1vz)

0,097.45

7.254.50

7.730.52

a

EQUITYAND

LIABILITIES

1

Equity(2)

Equitysharecapital

470

00

470

00

47000

(6)

otherEquity

3,03591

2,47031

1,80555

malEquin

5,505.91

2,540.51

2,278.55

Liabilities2

Non-current|

(a)

FinancialLiabi

ies

-

Burrowtngs

52354

1.29122

1,75424

(b)

Fmvtsmrls

10030

64

56

3012

(1:)

Omarnon-current

241

59

17565

112

50

TotalNan.

CurrentL‘ahil

075.53

1.54543

1,695.06

a

Currentabilities

(a)

FlnanclalLlabl

ies

(I)

Barraw

gs

500.40

523.11

525.70

(

)TraoaPayable:

1,75455

160375

1,02590

1,212.62

777.55

818.47

15556

17042

22611

(c)

FrovlSlons

95

12

69.75

64.02

TotalCurrentLiab

3,715.05

2.144.06

5,565,211

rotalEquityand

Liam

1es

(1~2~5)

“97.45

7.254.513

7.750.52

A:'

a“

Dr.

Agarwai'sEyeHospitallelted

CIN

:

L85110TN1954PLC027366

RegdOffice:3rd

Floor,EuhariTowers,Nn.4,MauresRoad,of!GrzamsRoad,Charm

600005

PhoneNo,914449916569Website:

mm.dragantval.comE-mail

'

vesthdragarwaltcam

(Amnuntin

Rs.

Lakhs)

Th!apove

auditedfinancialresultshavetreenreviewedby

the

AuditCommittee.approvedandtakenon

recordby

the

Boardoi

Directorsin

theirMeetingheldon

as

May2013,

2

TheCompanyhas

adoptedIndianAccountingStandard(“indAS")(rent1

Apni2:111witha

transitiondate(rum1

April2mandeooprdrngiy.thesetinan

ai

resultshaveoeen

preparedin

accordancewtnind

As

prescribedundersection133or

the

CompaniesAct.201:readwrrhrhe

relevantnriesissuedthereunderandthe

nth

accountingmind

as

generallyacceptedin

IndieJirerecon

on

betweenfinancialresolrsIortrrequarterandyear

endedCH

Maren2:117and

Eqully(or

the

yearended31

Marchmmand1

April2015.as

previouslyreported(relerredre

a

IndianGAAF‘)andInd

As

o

as

under.

(a)

statementor

reconciliationor

netpreirtIkartaxunderInd

As

andnotprotitattertaxreportedunderIndianGAAP(IGMP)torttrapreviousperiods:

(Amountin

Rs.

Lakrrsl

quarterEnded

YurEnded

Particulars

:11

March2011

:1

March2011

(ReterNote1

below)

(Audited)

Net

profitattertaxunder

Previouscw

312.25

55721

ActuanoiLosson

employeedonnedeenerrtiundsreeegnlsedin

otherComprehensiveIncome

45

04

40.75

Fairvalueadiustmenrs

-

Dopaens

14.90

52.30

Amprrisedcostediustments

a

ancialAssets

(13.76)

(5173)

Recognitionot

borrowingsat

amomzedowleasedon

EilecnvainterestRate

(1.59)

(a

56)

Provision(or

ExpectedCreditLosson

financialAssets

255

at

do

impactor

DelerredTaxin

respectottheaboveAdrusirnents

(15.42)

(«1.54)

Net

mm(orthe

periodunderindAs

34125

7:12:

othercomprehensrveLess(netoi

lax)

(25.73)

(25.65)

TotalComprehensiveIncomeunderIndAS

315.55

7117.15

(o)

Statementot

reeono

ationot

EquityunderIndAsandEquityreportedunderrndianem(IGAAF)as

a

(Amountin

Rs.

Lakhs]

As

at

As

or

Particulars

31

March1017

nt

Arr

znla

(Audited)

(Au

ted)

TotalEquilyas

reportedunderPreviousGAAP

2,599.32

2,142.11

ReversalniProposadDividendandDividendDistributionTax

-

45.25

Fairvalueadiustmarrts

—

Deposits

52.:tn

s

Amnrtisedcost

adluslmenu-

FinancialAssets

(93.12)

(4239)

Recognitionat

oorrowirrdsat

amortizedcostbasedon

EtiectiveInterestRail

17.55

2m)

Provrsren(or

ExpectedCreditLosson

financialAssets

(65.97)

(145.37)

Delerredtax

on

Ind

As

adiustrnenrs

31.23

57.57

-

TumEquityas

reportedunderIndAS

2

mm

2

27am

a

Thefigures(or

the

quartersendedat

March2015and

31

March2017are

the

palanclngnguresbetweenthe

auditedtigurestor

the

yearsended31

March2015and

31

March2017andthe

unauditedyearto

datefigurestor

the

nrne

months

ended31

Decemoerzanand:1

DecemberZME,respeonvely.which

weresubjectto

I

lied

reviewby

the

statutoryAuditors.

4

TheCampanyoperatesin

a

singlesegment

EyeCarereiarodsalesand

Serums“andhence,doesnothaveany

additionaldisclosuresto

he

madeunderind

As

we

-

OpereongSegments.

-

5

Thesteamut

Directorsat

its

meetingheldon

2a

May201:)haverecnmmsndeda

«netdividendor

Rs

1.2aper

equitysnaresumecflorne

approvalaltneshareholders.

av

orderot

the

aura

Dr.AmarAgarwal

Place:

ctr-rural

Chairman5

Managing

Date

.

25

May2nia

DIN

No.

ondaseao

Deloitte i23l§eéiin2f§¥2$f£5.

52, Venkalnarayana Road

. NHaskms & Sells 5,353,000,,Tamil Nadu, india

Tel: +91 44 6688 5000

Fax: +91 44 6688 5050

INDEPENDENT AUDITOR'S REPORT

TO THE BOARD OF DIRECTORS OF

DR. AGARWAL'S EYE HOSPITAL LIMITED

1. We have audited the accompanying Statement of Financial Results of

DR. AGARWAL'S EYE HOSPITAL LIMITED (“the Company”) for the year ended

31 March 2018 (“the Statement”), being submitted by the Company pursuant to the

requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015, as modified by Circular No. CIR/CFD/FAC/62/2016

dated 5 July 2016.

2. This Statement, which is the responsibility of the Company’s Management and

approved by the Board of Directors, has been compiled from the related Ind AS

financial statements which has been prepared in accordance with the Indian

Accounting Standards prescribed under Section 133 of the Companies Act, 2013 read

with relevant rules issued thereunder (‘Ind AS’) and other accounting principles

generally accepted in India. Our responsibility is to express an opinion on the

Statement based on our audit of such financial statements.

3. We conducted our audit in accordance with the Standards on Auditing issued by the

Institute of Chartered Accountants of India. Those Standards require that we complywith ethical requirements and plan and perform the audit to obtain reasonable

assurance about whether the Statement is free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts

and the disclosures in the Statement. The procedures selected depend on the

auditor’s judgment, including the assessment of the risks of material misstatement of

the Statement, whether due to fraud or error. In making those risk assessments, the

auditor considers internal control relevant to the Company’s preparation and fair

presentation of the Statement in order- to design audit procedures that are

appropriate in the circumstances, but not for the purpose of expressing an opinion on

the effectiveness of the Company’s internal control. An audit also includes

evaluating the appropriateness of the accounting policies used and the

reasonableness of the accounting estimates made by the Management, as well as

evaluating the overall presentation of the Statement.

We believe that the audit evidence obtained by us is sufficient and appropriate to

provide a basis for our audit opinion.

4. In our opinion and to the best of our information and according to the explanations

given to us, the Statement:

(i) is presented in accordance with the requirements of Regulation 33 of the SEBI

(Listing Obligations and Disclosure Requirements) Regulations, 2015, as

modified by Circular No. CIR/CFD/FAC/62/2016 dated 5 July 2016; and

(ii) gives a true and fair View in conformity with the aforesaid Indian AccountingStandards and other accounting principles generally accepted in India of the net

profit and Total comprehensive income and other financial information of the

Company for the year ended 31 March 2018.

Deloitte

Haskins & Sells

5. The Statement includes the results for the Quarter ended 31 March 2018 being the

balancing figure between audited figures in respect of the full financial year and the

published year to date figures up to the third quarter of the current financial year,

which were subject to limited review by us.

For DELOITI'E HASKINS & SELLS

Chartered Accountants

(Firm’s Registration No. 0080725)

\i WV Balaji

Partner

(Membership No. 203685)

CHENNAI, 28 May 2018

VB/JT/RB/2018/15

6 Dr. Agarwal'sEye Hospital Ltd.

For eyes like new

‘

May 28, 2018

Dept. of Corporate Services

Corporate Relationship Department

BSE Ltd

PhirozeJeejeebhai Towers,

Dalal Street,

Mumbai — 400001

Dear Sir,

Sub: Declaration in respect of Statutory Auditors' Report with Unmodified opinion ~

reg.

Ref: 1) Regulation 33 of the SEBI (LODR) Regulation, 2015

2) Scrip Code: 526783

We hereby declare that the Statutory Auditors of the Company, M/s. Deloitte Haskins & Sells (Firm

Registration Number 0080725), Chartered Accountants, Chennai, have issued the Audit Report

with Unmodified Opinion with respect to the Audited Financial Results for the Financial Year ended

31“ March 2018.

Kindly take the above information on record.

Thanking you,

Yours truly,

S. LAKSHMI NARASIMHAN

COMPANY SECRETARY & COMPLIANCE OFFICER

DR. AGARWAL'S EYE HOSPITAL LTD

Registered Office.

3'“ Floor, Buhari Towers, No.4, Moores Road, Ofl Greams Road, Near Asan Memorial School, Chennai - 600 006.

Tel: 91 -44-3991 6600 Fax: 91-44—3991 6645 .

Corporate ID Number: L8511OTN1994PLC027366 GST No. 33AAACD237SG122

Email: dragarwal@vsnl.com | Website: wwwdragarwalcom